Codiak BioSciences, Inc. Lease, Cost
Codiak BioSciences, Inc. reported Lease, Cost of $1.53 million for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-11-03.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseCost · last filed 2022-11-03
- Codiak BioSciences, Inc. lease, cost for the quarter ending 2022-09-30 was $1.53M, a 11.46% increase year-over-year.
- Codiak BioSciences, Inc. lease, cost for the quarter ending 2022-06-30 was $1.06M, a 26.95% decline year-over-year.
- Codiak BioSciences, Inc. lease, cost for the quarter ending 2022-03-31 was $1.06M, a 30.32% decline year-over-year.
- Codiak BioSciences, Inc. lease, cost for the quarter ending 2021-12-31 was $1.28M, a 8.67% decline year-over-year.
- Codiak BioSciences, Inc. lease, cost for fiscal 2021 was $5.64M, a 9.25% decline from fiscal 2020.
- Codiak BioSciences, Inc. lease, cost for fiscal 2020 was $6.22M.
| Period end | Lease, Cost 3 month | Lease, Cost 6 month | Lease, Cost 9 month | Lease, Cost 12 month |
|---|---|---|---|---|
| 2022-09-30 | $1.53M 10-Q · filed 2022-11-03 | $2.59M derived: sum of 2 quarters · filed 2022-11-03 | $3.66M 10-Q · filed 2022-11-03 | $4.94M derived: sum of 4 quarters · filed 2022-11-03 |
| 2022-06-30 | $1.06M 10-Q · filed 2022-08-04 | $2.13M 10-Q · filed 2022-08-04 | $3.41M derived: sum of 3 quarters · filed 2022-08-04 | $4.78M derived: sum of 4 quarters · filed 2022-11-03 |
| 2022-03-31 | $1.06M 10-Q · filed 2022-05-05 | $2.35M derived: sum of 2 quarters · filed 2022-05-05 | $3.72M derived: sum of 3 quarters · filed 2022-11-03 | $5.18M derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-12-31 | $1.28M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $2.65M derived: sum of 2 quarters · filed 2022-11-03 | $4.11M derived: sum of 3 quarters · filed 2022-11-03 | $5.64M 10-K · filed 2022-03-10 |
| 2021-09-30 | $1.37M 10-Q · filed 2022-11-03 | $2.83M derived: sum of 2 quarters · filed 2022-11-03 | $4.36M 10-Q · filed 2022-11-03 | $5.76M derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-06-30 | $1.46M 10-Q · filed 2022-08-04 | $2.99M 10-Q · filed 2022-08-04 | $4.39M derived: sum of 3 quarters · filed 2022-08-04 | $5.82M derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | $1.53M 10-Q · filed 2022-05-05 | $2.93M derived: sum of 2 quarters · filed 2022-05-05 | $4.36M derived: sum of 3 quarters · filed 2022-05-05 | $5.91M derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | $1.41M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $2.83M derived: sum of 2 quarters · filed 2022-03-10 | $4.38M derived: sum of 3 quarters · filed 2022-03-10 | $6.22M 10-K · filed 2022-03-10 |
| 2020-09-30 | $1.43M 10-Q · filed 2021-11-04 | $2.98M derived: sum of 2 quarters · filed 2021-11-04 | $4.81M 10-Q · filed 2021-11-04 | |
| 2020-06-30 | $1.55M 10-Q · filed 2021-08-05 | $3.38M 10-Q · filed 2021-08-05 | ||
| 2020-03-31 | $1.83M 10-Q · filed 2021-05-06 |